NCT01766518 - The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1) | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions

Evidence of Liver Transplantation

Interventions

DRUG

Mycophenolate mofetil

MY-REPT capsule 500\~1500mg/day, per oral, capsules twice a day with Tacrolimus, Corticosteroids, Basiliximab post liver transplantation

Trial Locations (3)

RECRUITING

Asan medical center, Seoul

COMPLETED

Samsung Medical Center, Seoul

COMPLETED

Seoul ST Mary's Hospital, Seoul